Klingman & Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $201K | Buy |
+382
| New | +$201K | 0.01% | 310 |
|
|
2025
Q1 | – | Sell |
-291
| Closed | -$207K | – | 272 |
|
|
2024
Q4 | $207K | Buy |
291
+34
| +13% | +$24.2K | 0.01% | 248 |
|
|
2024
Q3 | $270K | Buy |
257
+4
| +2% | +$4.21K | 0.02% | 225 |
|
|
2024
Q2 | $266K | Buy |
253
+2
| +0.8% | +$2.1K | 0.02% | 206 |
|
|
2024
Q1 | $242K | Buy |
251
+4
| +2% | +$3.85K | 0.02% | 216 |
|
|
2023
Q4 | $217K | Buy |
247
+3
| +1% | +$2.64K | 0.02% | 217 |
|
|
2023
Q3 | $201K | Buy |
+244
| New | +$201K | 0.02% | 213 |
|